6:45 a.m. |
Registration |
7:30 a.m. |
Introduction by Moderators |
7:35 a.m. |
2019 Harry Hirsch Leiter Award Recipient:
Validation of a Comprehensive Clinical Algorithm for the Assessment and Treatment of Microbial Keratitis
Lawson Ung , MD |
7:42 a.m. |
1. Antibiotic Resistance Among Bacterial Pathogens Isolated from the Cornea Over 11 Years of the ARMOR Surveillance Study
Penny A. Asbell, MD |
7:49 a.m. |
2. Characterization of Staphylococcus aureus Corneal Keratitis Isolates: A Whole Genome Perspective
William Johnson, PhD
|
7:56 a.m. |
3. Prospective Comparison of Clinico-microbiological Features and Management Outcomes in Infectious Endophthalmitis Caused by Biofilm Positive and Biofilm Negative Bacteria
Vivek Dave |
8:03 a.m. |
4. Diversity and Stability of the Microbiome in Ocular Surface Diseases
Michael J Zilliox |
8:10 a.m. |
5. Autologous Serum Eye Drops Alter the Stability of the Ocular Surface Microbiome
Katherine D Leviste, MS |
8:17 a.m. |
6. Assessment of the Impact of Sample Collection Order on the Diagnostic Performance of Metagenomic Deep Sequencing for Infectious Keratitis
Travis K Redd, MD, MPH
|
8:24 a.m. |
7. Evaluation of Metagenomic Deep Sequencing as a Diagnostic Test for Infectious Keratitis
Gerami D. Seitzman, MD
|
8:31 a.m. |
8. The Rcs Stress Response System Modulates Serratia marcescens Induced Inflammation and Bacterial Proliferation in a Rabbit Keratitis Model
Robert MQ Shanks, PhD
|
8:38 a.m. |
9. Pythium Keratitis: Outcome and Prognostic Factors
Bhupesh Bagga, FRCS
|
8:45 a.m. |
10. Treatment of Severe Infectious Keratitis with Scleral Contact Lenses as a Reservoir of Moxifloxacin 0.5%
Eduardo J Polania-Baron, MD
|
8:52 a.m. |
11. Rose Bengal Photodynamic Antimicrobial (RB-PDAT) & Standard Antibiotic Therapy for the Treatment of Severe Infectious Keratitis
Feras Mohder
|
8:59 a.m. |
12. Evaluation of Rose Bengal Photodynamic Antimicrobial Therapy as an Adjunctive Treatment for Severe Keratitis
Wirley Alves de Mendonça Júnior, MD
|
9:06 a.m. |
13. The Efficacy of Riboflavin Versus Rose Bengal Photodynamic Antimicrobial Therapy on South Florida Nocardia Keratitis Isolates
Ethan Adre
|
9:13 a.m. |
OPEN QUESTIONS AND COMMENTS |
9:18 a.m |
BREAK |
9:30 a.m. |
14. The Search for Antifungal Prophylaxis Following Artificial Cornea Surgery—An In Vitro Study
Sarah Kim
|
9:37 a.m. |
15. In vitro antiviral activity of Lumify and Besivance Two Benzalkonium Chloride Preserved Eye Drops Against SARS CoV-2
Kimberly A Millard, MS
|
9:44 a.m. |
16. SAVES: Recovery of SARS-CoV-2 from Aerosol Spread
Miel Sundararajan, MD
|
9:51 a.m. |
17. Filociclovir (MBX-400) Demonstrates Antiviral Activity against Adenovirus In Vitro and in the Ad5/NZW Rabbit Ocular Model
Eric G Romanowski, MS
|
9:58 a.m. |
18. Delayed Diagnosis and Presenting Characteristics of Acanthamoeba Keratitis at a Tertiary Medical Center
Nakul S Shekhawat, MD, MPH
|
10:05 a.m. |
19. Presence of Genomic Signatures of Giant Viruses in Formalin-fixed Cornea Tissues and Failed Grafts
Darlene Miller, DHSc
|
10:12 a.m. |
OPEN QUESTIONS AND COMMENTS |
10:17 a.m. |
20. Matrix Metalloproteinase 9 Positivity Predicts Long Term Decreased Tear Production
Matias Soifer
|
10:24 a.m. |
21. Correlation between Active Central Corneal Ulceration with the Inflammatory Status of Systemic Autoimmune Disease
Luis Alberto Rodriguez Gutierrez, MD |
10:31 a.m. |
22. Proinflammatory Cytokines Induce Inflammasome-mediated Corneal Endothelial Cell Death
Andres Serrano MD
|
10:38 a.m. |
23. Clinicopathologic Correlations of Retrocorneal Membranes Associated with Endothelial Corneal Graft Failure
Andrea Naranjo, MD
|
10:45 a.m. |
24. Comparison of Corneal Nerve Alterations in Patients with Autoimmune-Mediated Neuropathic Corneal Pain
Leyla Yavuz-Saricay, MD
|
10:52 a.m. |
25. Corneal Microneuromas and Dry Eye
Jodi Hwang, BS
|
10:59 a.m. |
OPEN QUESTIONS AND COMMENTS |
11:05 a.m. |
BREAK |
11:15 a.m. |
Thygeson Lecture: “Why Do Dry Eyes Get Inflamed?”
Stephen C Pflugfelder MD
Professor and James and Margaret Elkins Chair in Ophthalmology
Baylor College of Medicine
|
12:00 p.m. |
Closing Comments and Awards |
12:15 p.m. |
Business Luncheon -- via Zoom |